A novel inhibitor for MEK1 kinase: MST found it!

End of last year, Sanofi and NanoTemper Technologies released a publication describing an automated MicroScale Thermophoresis (MST) affinity screening approach to identify fragments active against the cancer target MEK1 kinase.